Skip to content

VR for Cataract Anxiety Lowering Management

A Non-Randomized Controlled Trial of Virtual Reality Simulation of Intraoperative Audiovisual Experience to Reduce Anxiety in Cataract Surgery Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07586280
Acronym
VR-CALM
Enrollment
60
Registered
2026-05-14
Start date
2026-05-01
Completion date
2026-06-30
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract and Intraocular Lens Surgery, VR-based Informed Consent

Brief summary

Cataract is currently the leading cause of blindness globally, and surgery is the only effective treatment. With the advancement of medical technology, cataract surgery is usually performed under topical anesthesia, which means patients will be awake during the procedure, able to see the light from the surgical lamp and hear the sounds of surgical instruments being operated. Some patients may feel nervous or scared due to unfamiliarity with the surgical process, which may lead to increased blood pressure, rapid heartbeat, and even affect their cooperation during the surgery. Virtual reality (VR) technology is a new multimedia technology. By wearing VR glasses, patients can immerse themselves in a virtual world and see and hear realistic scenes. Through this study, the investigators aim to investigate whether allowing cataract patients to "experience" a surgical procedure in advance through VR glasses before cataract surgery can help alleviate their nervousness during the actual surgery.

Interventions

This Virtual reality video simulates the audiovisual experience of phacoemulsification (Phaco and IOL) surgery

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with cataracts in both eyes, and planning to undergo surgical treatment 2. Voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

1. Having any history of previous ophthalmic surgery. 2. Suffering from severe hearing impairment, unable to comprehend VR video content. 3. Those who suffer from cognitive dysfunction or mental illness and are unable to cooperate in completing the scale assessment. 4. Suffering from severe macular diseases, glaucoma, or other ocular diseases that may affect surgery or interfere with the assessment of tension level. 5. Assessed as intolerant to surface anesthesia surgery. 6. History of motion sickness, severe vertigo, or intolerance to VR video viewing (such as claustrophobia). 7. Other situations where the researcher deems the participant unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative anxiety numerical rating scale (NRS)collected immediately after the surgeryIntraoperative participants self-reported anxiety level using numerical rating scale (NRS), from 0 (no anxiety) to 10 (highest anxiety)

Secondary

MeasureTime frameDescription
Heart ratecollected during the surgeryHeart rate at various intraoperative time points (before capsulorhexis, during phacoemulsification, and after intraocular lens implantation).
Blood Pressurecollected during the surgerySystolic blood pressure and diastolic blood pressure at various intraoperative time points (before capsulorhexis, during phacoemulsification, and after intraocular lens implantation).
Pain Numerical Rating Scale (NRS)collected immediately after the surgeryIntraoperative participants self-reported pain level using numerical rating scale (NRS), from 0 (no pain) to 10 (highest pain)
Cooperation Numerical Rating Scale (NRS)collected immediately after the surgeryThe numerical rating scale (NRS) score of patient cooperation level assessed by the surgeon, from 0 (very bad cooperation) to 5 (very good cooperation)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026